Canada got green light for First plant-based vaccination against Covid-19

A unit of Mitsubishi Chemical Holdings Corp. and Philip Morris International has received approval to utilise the world’s first plant-derived Covid-19 vaccine in Canada, resulting in a novel immunisation to combat the virus.
Medicago Inc., a biopharmaceutical business established in Quebec City and owned by Mitsubishi Chemical and Philip Morris, and GlaxoSmithKline Plc collaborated on the Covifenz vaccine. Adults aged 18 to 64 will be allowed to use it, according to a statement released by Medicago and Glaxo on Thursday.

The approval gives people who are hesitant to take currently available vaccines made by Pfizer Inc., AstraZeneca Plc and Moderna Inc. another option. Many countries are struggling to raise vaccination rates and are requiring citizens to be immunized to get into restaurants, shopping malls trains and planes.

The company hopes Covifenz will generate about $1 billion a year eventually, Mitsubishi Chemical’s Chief Executive Officer Jean-Marc Gilson said in an interview last week. The vaccine is easier to transport and store than rival mRNA shots, such as those from Pfizer and Moderna, since it doesn’t need to be kept at ultra-low temperatures, he said.

Covifenz is made from proteins, grown in plants, that look like the virus that causes Covid-19 to the human immune system, according to Medicago’s website. The vaccine also uses Glaxo’s pandemic adjuvant, a substance that boosts the immune system’s response.

Medicago has a contract with the Canadian government to supply up to 76 million doses of the vaccine and is in talks with other countries about potential agreements, Chief Executive Officer Takashi Nagao has said. The immunization was granted fast-track designation by the U.S. Food and Drug Administration in February 2021.

The vaccine demonstrated 71% efficacy against multiple variants of the virus in December, Medicago said. It was 75% effective against the highly-infectious delta variant and nearly 89% effective against the gamma variant first identified in Brazil. The omicron variant wasn’t circulating when the trial was conducted, and the company is planning future tests against that strain.

Medically Speaking

Recent Posts

A NUTRITIONAL POWERHOUSE: THE ROLE OF POMEGRANATE IN FERTILITY AND REPRODUCTIVE HEALTH

Throughout history, the pomegranate has been a revered fruit, not only for its vibrant appearance…

59 mins ago

“Unlock Radiant Skin: The Secrets of Essential Nutrients and How They Boost Your Health”

Secrets of Essential Nutrients: How Vitamins, Proteins, and Fats Boost Your Health and Keep Your…

2 hours ago

“Watch: Expert Tips in This Video to Safeguard Your Health from Air Pollution!”

Air Pollution Awareness: Did you know that rising air pollution can have a serious impact…

2 hours ago

“Video: Uncovering the Hidden Link Between Obesity and Diabetes – Risks, Science, and Prevention Tips”

Obesity vs Diabetes: In this video, we discuss the strong connection between obesity and diabetes.…

2 hours ago

“5 Superfoods to Naturally Boost Collagen and Rejuvenate Your Skin, Hair, and Joints”

5 Foods to Naturally Increase Collagen Production Collagen is one of the most abundant proteins…

2 hours ago

“Heart Attack Warning: THIS Common Gum Issue Could Signal Early Risk—Don’t Ignore It!”

Heart Attack Symptom: THIS Sign in Your Mouth Can Help in Early Detection Heart disease…

3 hours ago